Quick access

Full HTML PDF
Share Article:
2020 Volume 11 Issue 2

Evidence that supports the antidiabetic, antihypertensive, and antihyperlipidemic effects of olive (Olea europaea L.) leaves extract and its active constituents (oleuropein) in human


Heba A. Sindi
Abstract

The Kingdom of Saudi Arabia is one of the countries in the Middle East burdened with type 2 diabetes (T2D). This type of diabetes is associated with an increase in the body's resistance to insulin action. Elevated blood pressure is one of the most important diseases that accompany T2D. Many experimental and clinical studies have shown the effectiveness of olive leaves extract (OLEx) in controlling T2D, as well as hypertension. This review aimed to collect clinical studies conducted in humans that prove the effectiveness of OLEx or its active constituent (oleuropein) in combating T2D, hypertension, and hypolipidemia. Several studies conducted in humans (diseased and healthy) showed the effectiveness of OLEx or oleuropein in reducing both blood glucose and lipids. It also improved the vascular functions and reduced inflammation associated with high blood pressure and diabetes. The mechanisms behind these pharmacological activities were to scavenge free radicals, increase insulin production, and reduce its resistance, raise nitric oxide synthesis, and dilate blood vessels. From toxicological studies in experimental animals, it has been shown that the OLEx may be safe to use. In conclusion, studies on humans showed the effectiveness of OLEx in managing T2D, hyperlipidemia, and hypertension, but there were limited-number trials and did not use large numbers of participants, and therefore large studies must be conducted to document effectiveness and safety of OLEx.


How to cite this article
INDEXING
Chemical Abstracts, EBSCOhost databases, ABCD Journl Index, Asian Science Citation Index (ASCI), CABI (CAB Abstracts) and many other international scientific databases.

JOURNAL OF BIOCHEMICAL TECHNOLOGY
JOURNAL OF BIOCHEMICAL TECHNOLOGY
Journal of Biochemical Technology is a double-blind peer reviewed International Journal published by the Deniz Publication on behalf of the Biochemical Technology Society, a Registered Charity Organization from India

ABOUT US
ABOUT US
Welcome to the Journal of Biochemical Technology, a prestigious international double-blind peer-reviewed journal dedicated to advancing excellence in biochemical, biotechnological, and bioinformatics research with direct applications in biology and medicine.

AIM AND SCOPE
AIM AND SCOPE
The Journal of Biochemical Technology is dedicated to publishing innovative research in the fields of biochemistry, biotechnology, and bioinformatics with direct applications in biology and medicine.

Publish with us


Deniz Publication
Guzelyali Mah. Sahilyolu Cad.Defne Sok. No: 7, 34903 Pendik, Istanbul
Email: [email protected]
Tell: +905344990778
Associations

Publishing steps

1.Prepare
your paper
2.Submit
and revise
3.Track
your research
4.Share
and promote
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Keywords include, Biochemical Research: Endo/exocytosis, Trafficking, Membrane Biology, Cell Migration, Cell-Matrix Organelle Biogenesis, Cytoskeleton Proteolysis, Cell Death, Cell Cycle, Cancer, Cell Growth/Death, Differentiation, Drug Targets, Gene Therapy, Models of Disease, Proteomics, Stem Cells, Bioenergetics, Mitochondria, Free Radicals, Redox Signaling, Ion Transport/Channels, Oxidative